Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators-Reference-Cited by-同舟云学术

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators

Published:1985-01 Issue:4 Volume:1 Page:325-337
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Bhathal Prithi S.,Grossman Howard J.

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. Role of splanchnic venous system in overall cardiovascular homeostasis;Greenway,1983

2. Hyperdynamic circulation in portal-hypertensive rat model — A primary factor for maintenance of chronic portal hypertension;Vorobioff;Amer. J. Physiol.,1983

3. Diseases of the Liver and Biliary System;Sherlock,1981

4. Vascular lesions of portal cirrhosis;McIndoe;Arch. Path. Lab. Med.,1928

5. The relation of the regenerated liver nodule to the vascular bed in cirrhosis;Kelty;Gastroenterology,1950

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Treatment of Portal Hypertension;Clinics in Liver Disease;2024-08

2. The liver sinusoid in chronic liver disease: NAFLD and NASH;Sinusoidal Cells in Liver Diseases;2024

3. B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review;Biomedicines;2023-12-25

4. Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways;European Journal of Pharmacology;2023-11

5. Complicaciones agudas del paciente cirrótico. Ascitis, encefalopatía hepática y síndrome hepatorrenal;Medicine - Programa de Formación Médica Continuada Acreditado;2023-11